Breast Health

COVID-19

Cervical Health 

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Sexual Health

Sexually Transmitted Infections

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Investigator Perspectives

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Partnerships

Articles

A retrospective study finds comparable pregnancy rates between PPOS and GnRH antagonist protocols, with a trend toward improved blastocyst outcomes in PPOS cycles.

Similar IVF outcomes reported for PPOS and GnRH antagonist protocols

She joined the MJH Life Sciences team in December 2019. She graduated from Youngstown State University in 2019 with a bachelor's degree in journalism and a minor in political science. Prior to graduating, Morgan worked as the editor-in-chief of her college newspaper. She went on to work as an assignment editor at a broadcast news station in Youngstown, Ohio, before joining 

 You can reach her at mebert@mjhlifesciences.com.

A new study shows extrauterine cerebellar ultrasound is a reliable, low-cost method to assess gestational age after fetal or neonatal death, especially in low-resource settings.

Postmortem ultrasound accurately estimates gestational age

Vaccinating pregnant women at least 5 weeks before delivery significantly improves transplacental transfer of respiratory syncytial virus antibodies, offering better early protection for infants.

Early RSV vaccination in pregnancy boosts antibody transfer to newborns

Joshua Fitch is an editor for Contemporary Pediatrics. Previously, he worked at 21 WFMJ as a sports anchor and videographer, as well as a national content writer for Weigel Broadcasting Company. 

Childhood adversity may raise endometriosis risk, with exposure to violence linked to a twofold increase, a Swedish study finds.

Study finds childhood adversity linked to elevated risk of endometriosis

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Facebook

LinkedIn

RSS Feed

Spotlight

A Psychedelic to Treat Postpartum Depression?

CMV: In the Know

RSV Roundtable

STIs

Supplement: Closing the Gap in Cervical Cancer Screening

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

View

Updated Phase III MIRASOL Trial Results: Mirvetuximab Soravtansine vs Chemotherapy in Platinum-Resistant Ovarian Cancer with High Folate Receptor-Alpha Expression 

Lan Coffman, MD, PhD, discusses results and clinical implications derived from the findings of the phase III MIRASOL trial.

Dr Coffman breaks down the findings from the phase III MIRASOL trial, and provides insight surrounding the treatment options and potential clinical implications surrounding ovarian cancer treatment.

Updated Phase III MIRASOL Trial Results: Mirvetuximab Soravtansine vs Chemotherapy in Platinum-Resistant Ovarian Cancer with High Folate Receptor-Alpha Expression

Updated Phase III MIRASOL Trial Results: Mirvetuximab Soravtansine vs Chemotherapy in Platinum-Resistant Ovarian Cancer with High Folate Receptor-Alpha Expression

EP: 1.Updated Phase III MIRASOL Trial Results: Mirvetuximab Soravtansine vs Chemotherapy in Platinum-Resistant Ovarian Cancer with High Folate Receptor-Alpha Expression